- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Cerebral Hemorrhage in Belgium
Total 414 results
-
Centre Hospitalier Universitaire de Saint EtienneInstitut de Cancérologie de la LoireCompletedMultiple Myeloma | Renal FailureFrance, Belgium, Algeria, Lebanon
-
Amicus TherapeuticsCompletedOpen-Label Extension Study of the Long-Term Effects of Migalastat HCL in Patients With Fabry DiseaseFabry DiseaseUnited States, Austria, United Kingdom, Argentina, Australia, Belgium, Brazil, Canada, Denmark, Egypt, France, Italy, Japan, Spain, Turkey
-
Intergroupe Francophone du MyelomeUnknown
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireCompletedHemophilia AUnited States, Belgium, France, Norway, Netherlands, Austria, Hungary, Italy, Poland, Portugal, Romania, Russian Federation, Spain, Sweden
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaUnited States, Belgium, United Kingdom, Netherlands, France, Australia
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, Belgium, United Kingdom, France, Australia
-
Novo Nordisk A/SActive, not recruitingHaemophilia A With Inhibitors | Haemophilia ASpain, Korea, Republic of, Canada, United Kingdom, United States, Germany, South Africa, Italy, Austria, Belgium, France, Japan
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaKorea, Republic of, Russian Federation, Spain, Germany, Belgium, Denmark, Greece, France, United States, Ukraine, Poland
-
CelgeneCompletedMultiple MyelomaFrance, Belgium
-
CENTOGENE GmbH RostockShire Human Genetic Therapies, Inc.CompletedCerebrovascular AccidentAustria, Belgium, Croatia, Finland, France, Georgia, Germany, Ireland, Italy, Malta, Poland, Portugal, Spain, United Kingdom
-
Ablynx, a Sanofi companyCompletedAcquired Thrombotic Thrombocytopenic PurpuraUnited States, Austria, Belgium, France, Germany, Israel, Italy, Spain, Switzerland, United Kingdom, Bulgaria, Romania, Australia
-
BayerPopulation Health Research InstituteCompletedAcute Non-cardioembolic Ischemic StrokeSpain, Japan, Australia, Czechia, Sweden, United Kingdom, Netherlands, Belgium, Russian Federation, Hungary, Slovakia, China, Germany, Switzerland, France, Poland, Denmark, United States, Austria, Bulgaria, Finland, Italy, Portugal
-
University Hospital, LilleJanssen, LP; Intergroupe Francophone du MyelomeCompletedMultiple MyelomaFrance, Belgium
-
Novartis PharmaceuticalsCompletedPrimary Myelofibrosis | Post-Essential Thrombocythemia Myelofibrosis | Post-Polycythemia Vera-MyelofibrosisBelgium, Italy, Spain, Bulgaria, Turkey, Greece, Russian Federation, Austria, Canada, Japan, Germany
-
OctapharmaRecruitingHaemophilia ABelgium, Italy, United States, Azerbaijan, Belarus, Canada, Estonia, France, Germany, Hungary, Lithuania, Russian Federation, Spain, Turkey, United Kingdom, Mexico
-
Regeneron PharmaceuticalsRecruitingMultiple MyelomaBelgium, United States, Japan, Korea, Republic of, Germany, Spain, United Kingdom
-
AmgenCompletedRelapsed or Refractory Multiple MyelomaUnited States, Belgium, Australia, Spain, Canada, Netherlands
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, Belgium, Germany, Netherlands, Israel, Spain, Saudi Arabia, France
-
SanofiRecruitingThrombotic Thrombocytopenic PurpuraItaly, Belgium, France, Greece, United States, Austria, Canada, Czechia, Germany, Japan, Netherlands, Spain, United Kingdom
-
Hoffmann-La RocheRecruitingMultiple MyelomaUnited States, Italy, Spain, Australia, Belgium, Israel, Germany, France
-
TakedaTakeda Development Center Americas, Inc.Active, not recruitingLymphoma | Multiple Myeloma | AmyloidosisUnited States, China, Belgium, Canada, Poland, Spain, Korea, Republic of, Greece, Singapore, Japan, Sweden
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaUnited States, Belgium, China, Israel, Netherlands, Spain, Japan
-
InflaRx GmbHCompletedGranulomatosis With Polyangiitis (GPA) | Microscopic Polyangiitis (MPA)Germany, Russian Federation, Belgium, France, Spain, Czechia, Italy, Netherlands, Sweden, Switzerland, United Kingdom
-
Idorsia Pharmaceuticals Ltd.Active, not recruitingFabry DiseaseUnited States, United Kingdom, Norway, Germany, Australia, Canada, Spain, Switzerland, Austria, Belgium, France, Netherlands, Poland
-
AstraZenecaCompletedIschemic Attack, Transient | Stroke, Acute | Cerebral Stroke | Cerebrovascular StrokeUnited States, Australia, Brazil, Bulgaria, Czech Republic, France, Korea, Republic of, Mexico, Poland, Russian Federation, South Africa, Spain, United Kingdom, Philippines, China, Germany, Hungary, Hong Kong, Argentina, Austria, Cana... and more
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A | Haemophilia BBelgium, Germany, France, United Kingdom, Italy, Hungary, Austria, Sweden, Iran, Islamic Republic of, Argentina, Ireland, Poland, Portugal, Slovakia
-
CelgeneTerminatedMultiple MyelomaUnited States, Canada, Spain, Italy, Denmark, United Kingdom, Belgium, Sweden, Germany
-
Idorsia Pharmaceuticals Ltd.CompletedFabry DiseaseUnited States, Spain, Belgium, Australia, Austria, Canada, Germany, Ireland, Italy, Netherlands, Norway, Poland, Switzerland, United Kingdom
-
Janssen Pharmaceutica N.V., BelgiumRecruitingRelapsed/Refractory Multiple MyelomaGermany, Italy, Belgium, Spain, Netherlands, France, United Kingdom
-
Eli Lilly and CompanyCompletedPostmenopausal OsteoporosisUnited States, Germany, Hungary, Italy, Spain, Belgium, France, Poland, Austria, Canada, Puerto Rico, Argentina, Greece, Brazil, Czechia
-
Ablynx, a Sanofi companyCompletedAcquired Thrombotic Thrombocytopenic PurpuraUnited States, Australia, Austria, Belgium, Canada, Czechia, France, Germany, Hungary, Israel, Italy, Netherlands, Spain, Switzerland, Turkey, United Kingdom
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedHemophilia APoland, Belgium, France, Italy, Spain, United States, Australia, Netherlands, New Zealand, Sweden, Germany, Finland, Hungary
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsSaudi Arabia, Algeria, Turkey, Germany, Poland, Netherlands, Italy, Belgium, South Africa, United Kingdom, Sweden, Austria, Portugal, France, Czech Republic, Venezuela
-
Hoffmann-La RocheActive, not recruitingSevere Hemophilia ACanada, United States, United Kingdom, Belgium, Australia, Austria, Brazil, France, Germany, Israel, Italy, South Africa, Spain, Turkey
-
Janssen-Cilag International NVCompletedMultiple MyelomaFrance, Poland, Belgium, Germany, Israel, Portugal, Turkey, Finland, Sweden, Netherlands, Norway
-
PedNet Haemophilia Research FoundationLund University HospitalRecruitingFactor IX Deficiency | Factor VIII DeficiencyNorway, Austria, Belgium, Canada, Czechia, Denmark, Finland, France, Germany, Greece, Ireland, Israel, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland, United Kingdom
-
Bristol-Myers SquibbJanssen, LPActive, not recruitingMultiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin's LymphomaUnited States, Poland, Italy, Belgium, France, Greece
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaBelgium, Korea, Republic of, Australia, United Kingdom, France, Sweden, Spain, Turkey, Italy, Czechia, Netherlands, Poland, Switzerland, Germany
-
BayerCompletedHemophilia ABelgium, New Zealand, Netherlands, Greece, United Kingdom, Austria, United States, Italy, Romania, Bulgaria, Canada, Israel, Poland, Lithuania, Norway, Argentina, Spain
-
BioMarin PharmaceuticalActive, not recruitingHemophilia AUnited States, Taiwan, United Kingdom, Australia, Israel, Belgium, Brazil, France, Germany, Italy, Korea, Republic of, South Africa, Spain
-
Hoffmann-La RocheActive, not recruitingHemophilia A | Mild Hereditary Factor VIII Deficiency Disease Without Inhibitor | Moderate Hereditary Factor VIII Deficiency Disease Without InhibitorUnited States, Netherlands, Belgium, France, Germany, South Africa, Spain, Canada, United Kingdom, Poland
-
Bristol-Myers SquibbAbbVieActive, not recruitingMultiple MyelomaUnited States, Canada, Australia, Poland, Italy, Belgium, Spain, Japan, Greece, Hungary, Romania, Turkey, United Kingdom
-
Bioverativ, a Sanofi companyCompletedFactor VIII DeficiencyUnited States, Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Spain, Taiwan, United Kingdom
-
CSL BehringActive, not recruitingHemophilia BUnited States, Belgium, Netherlands, Denmark, Germany, Ireland, Sweden, United Kingdom
-
Janssen Research & Development, LLCBristol Myers Squibb Company (BMS)RecruitingIschemic Stroke; Ischemic Attack, TransientItaly, United States, Hong Kong, Japan, Taiwan, Korea, Republic of, Israel, United Kingdom, Argentina, Belgium, New Zealand, Canada, Germany, Denmark, Mexico, Croatia, France, Australia, Brazil, China, Czechia, Hungary, Netherlands, S... and more
-
Centocor, Inc.WithdrawnMultiple MyelomaCanada, United States, Belgium, Poland, Bulgaria, Turkey, Ukraine, Australia, Korea, Republic of, New Zealand, Czech Republic, United Kingdom, Netherlands, India
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Canada, Denmark, Australia, Belgium, Finland, Greece, Japan, Korea, Republic of, Spain, United Kingdom
-
Karyopharm Therapeutics IncCompletedMultiple MyelomaUnited States, Belgium, Austria, France, Germany, Greece
-
University Hospital, ToulouseCelgene; Intergroupe Francophone du MyelomeCompleted
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Belgium, France, Norway